Top Story

Apellis to acquire Potentia Pharmaceuticals

November 21, 2014

Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals, according to a press release.

Through the agreement, Apellis obtained the necessary intellectual property rights to develop a complement inhibitor drug compound (APL-2) for the treatment of dry age-related macular degeneration.

thumbnail for video 3903679109001 Meeting News CoverageVideo

VIDEO: Management of zonular dehiscence

November 21, 2014
NEW YORK — At OSN New York 2014, Cynthia Matossian, MD, discusses strategies for handling cases of zonular dehiscence in cataract surgery.

Imprimis reports $2.5 million net loss in third quarter

November 21, 2014
Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million, or $0.23 per common…

Ocular Therapeutix to evaluate sustained-release travoprost for glaucoma, ocular hypertension

November 21, 2014
Ocular Therapeutix has begun enrolling the first subjects in a phase 2b clinical trial to evaluate the safety and efficacy of sustained-release travoprost, according to…

Valeant announces $2 billion Securities Repurchase Program

November 20, 2014
A new securities repurchase program that will allow Valeant Pharmaceuticals to make purchases up to $2 billion of its senior notes, common shares and other securities…
More News Headlines »
Original Article

Clinical Outcomes With a Trifocal Intraocular Lens: A Multicenter Study

Journal of Refractive Surgery, November 2014, Volume 30 Issue 11
To evaluate the clinical results and safety obtained with a new type of multifocal intraocular lens (IOL) using a…
More »
CME
In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD

In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

Dry age-related macular degeneration has proven to be a challenging condition for clinicians, and no pharmaceutical…
More »
Meeting News Coverage Video
thumbnail for video 3900080232001

Surgeon gives pearls for dislocated IOLs

November 19, 2014
NEW YORK — At the OSN New York meeting here, Uday Devgan, MD, discusses pearls for properly diagnosing and…
More »
morganatic-roan
morganatic-roan